跳至主要内容
临床试验/NCT06094816
NCT06094816招募中4 期

Forebrain Electroneutral Transporters in Salt-sensitive Hypertension: an MRI Study

University of Delaware1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年3月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
120
试验地点
1
主要终点
Bold fMRI

研究概览

简要总结

The overall objective of this project is to identify the key salt-sensing regions of the brain and determine the underlying mechanism of sodium sensing. The investigators will assess how the brain responds to an acute increase of salt in the blood using MRI. This will be done during a 30-minute infusion of a saline solution containing 3% salt. One trial will be conducted with a salt sensing channel blocker and one trial without the salt sensing channel blocker. This will help to assess the role of a specific salt sensing channel in the brain. Salt sensitivity of BP will be assessed using 7-day dietary feeding where participants will be given food to consume for 7-days. Comparisons will be made between salt resistant (no change in blood pressure going from low to high salt diets) and salt sensitive adults (a change in blood pressure going from low to high salt diets). The investigators think the changes in MRI will be greater in salt sensitive compared to salt resistant subjects.

详细描述

The ability of the brain to sense changing sodium levels in the blood is critical in mediating the neurohumoral responses to hypernatremia, however, the mechanisms underlying sodium sensing in humans is poorly understood. The purpose of this study is to identify key sodium-sensing regions of the human brain in middle-aged men and women with high blood pressure and determine if the Na-K-2Cl co-transporter (NKCC2) mediates the neurohumoral response to acute hypernatremia. The investigators plan on comparing these central sodium responses to acute hypernatremia between salt-sensitive and salt-resistant adults. In this randomized double-blinded crossover study subjects will have a 3% NaCl (hypertonic saline) infusion with or without NKCC2 antagonism (furosemide). Completion of this project will increase the understanding of blood pressure regulation, which has major public health implications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
40 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age: > 40 years or < 60 years
  • Blood pressure: > 100/60 mmHg or < 140/90 mmHg
  • BMI: > 18.5 kg/m2 or < 35 kg/m2
  • Serum potassium: > 3.5 mmol/L or < 5.5 mmol/L
  • No history of cardiovascular, renal, metabolic, or neurological disease

排除标准

  • Age: < 40 years or > 60 years
  • Blood pressure: < 100/60 mmHg or > 140/90 mmHg
  • BMI: < 18.5 kg/m2 or > 30 kg/m2
  • Serum potassium: < 3.5 mmol/L or > 5.5 mmol/L
  • Abnormal ECG
  • History of - cardiovascular, cancer, metabolic, respiratory, renal disease
  • Hormone replacement therapy
  • Current tobacco or nicotine use
  • Pregnant or nursing mothers
  • Major brain injury (concussions do not count)
  • Clinically diagnosed psychiatric or neurological disorder
  • Clinically diagnosed anxiety or depression
  • Psychiatric, neurological, anxiety or depression medications
  • Hypertension medications
  • Sulfonamide drug allergy
  • Contra-indications to MRI (implants, metal, etc)
  • Claustrophobia

研究组 & 干预措施

Salt Resistant Adults

Experimental

Adults who experience minimal BP change during dietary sodium challenge

干预措施: Furosemide (Diuretic) (Drug)

Salt Resistant Adults

Experimental

Adults who experience minimal BP change during dietary sodium challenge

干预措施: Hypertonic Saline Infusion (Other)

Salt Sensitive

Experimental

Adults who experience increased BP (mean arterial pressures >5mmHg) during dietary sodium challenge

干预措施: Furosemide (Diuretic) (Drug)

Salt Sensitive

Experimental

Adults who experience increased BP (mean arterial pressures >5mmHg) during dietary sodium challenge

干预措施: Hypertonic Saline Infusion (Other)

结局指标

主要结局

Bold fMRI

时间窗: 1 hour

Intensity of sodium sensing regions of the brain

次要结局

  • Blood Pressure(1 hour)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验